A carregar...
Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer
Although there are molecularly distinct subtypes of prostate cancer, no molecular classification system is used clinically. The ribonucleotide reductase small subunit M2 (RRM2) gene plays an oncogenic role in many cancers. Our previous study elucidated comprehensive molecular mechanisms of RRM2 in p...
Na minha lista:
| Publicado no: | Mol Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7400792/ https://ncbi.nlm.nih.gov/pubmed/32385899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12706 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|